Dihydroproscar
CAS: 98319-24-5
Ref. 3D-FD21922
| 10g | 202.00 € | ||
| 25g | 406.00 € | ||
| 50g | 602.00 € | ||
| 100g | 722.00 € | ||
| 250g | 1,079.00 € |
Product Information
- 3-Oxo-4-aza-5α-androstane-17β-(N-tert-butylcarboxamide)
- 17β-(N-tert-Butylcarbamoyl)-4-aza-5α-androstan-3-one
- 3-Oxo-4-Aza-5A-Androstane-17B-(N-T-Butyl)Carboxamide
- (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
- Androstane-N-terbutyl-3-oxo-4-aza-5 alfa-17 beta-carboxamide
- 17-Beta-(N-Butylcarbamoyl)-4-Aza-5-Alpha-Androstan-3-One
- 17β-(t-Butylcarbamoyl)-4-aza-5a-androstan-3-one
- N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide
- Dihydro Finasteride
Dihydroproscar is a synthetic retinoid that is clinically used to treat benign prostatic hyperplasia (BPH). It has been shown to inhibit the synthesis of 3β-hydroxysteroid, which is necessary for the conversion of testosterone to dihydrotestosterone. Dihydroproscar also has a denaturing effect on proteins and inhibits the in vitro synthesis of DNA and RNA. The second-order rate constant for the reaction of dihydroproscar with ribonucleotides is about 1.4 times faster than that for other retinoids. Dihydroproscar has pharmacokinetic properties that are similar to those of other retinoids, including fatty acids and hydrogen chloride.
Chemical properties
Technical inquiry about: 3D-FD21922 Dihydroproscar
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
